Literature DB >> 16978806

Modulatory effects of Aroclors 1221 and 1254 on bone turnover and vertebral histology in intact and ovariectomized rats.

Bayram Yilmaz1, Ayse D Seyran, Suleyman Sandal, Mehmet Aydin, Neriman Colakoglu, Muzaffer Kocer, David O Carpenter.   

Abstract

Polychlorinated biphenyls (PCBs) are persistent environmental pollutants. Two PCB mixtures, Aroclors 1221 and 1254 have been suggested to have estrogenic and anti-estrogenic properties, respectively. We have examined whether these PCB mixtures modulate bone turnover and vertebral histology in intact and ovariectomized (ovx) rat models. Thirty-two adult female rats were divided into four groups subcutaneously receiving 4% DMSO (control), A1221 (10 mg/kg), A1254 (10 mg/kg) oestradiol (E2, 30 microg/kg). These compounds were injected to the animals for a period of 6 weeks at two daily intervals. In the second model, rats (n=32) were ovx and allowed to recover for a period of 3 weeks. Control group received vehicle (4% DMSO) alone. Remaining rats were divided into three groups and injected (s.c.) with A1221, A1254 and E2 for 5 weeks. Urine samples were collected prior to end of the experiments. Then, all animals were decapitated. Serum parathyroid hormone (PTH), calcitonin and osteocalcin levels were determined by immunoradiometric method. Serum concentrations of alkaline phosphatase (ALP), calcium and inorganic phosphate were determined by enzymatic-colorimetric method. Urinary deoxypyridinoline (DPD) was measured by ELISA. Lumbar vertebrae (L2) of all animals were dissected out and processed for light microscopy. Levels of urinary DPD were significantly lowered in E2 -treated intact rats (p<0.001). Ovx significantly increased urinary DPD excretion (p<0.01) compared to intact control values. Administration of A1221 and A1254 had no significant effects in intact rats, however, they significantly reduced (p<0.05) and increased (p<0.001) urinary DPD levels in ovx rats, respectively. Neither of the PCB mixtures significantly changed serum osteocalcin and ALP levels in intact or ovx rats (except A1221 increased ALP in intact model, p<0.01). Both PCB mixtures had differential effects on serum PTH, calcitonin, calcium and inorganic phosphate concentrations. Treatment with A1221 reversed the adverse effects of ovariectomy on L2 histology. However, A1254 produced necrotic areas in vertebral bone, and this effect was expanded in ovx animals. Our findings suggest that both Aroclor compounds interfere with bone turnover mechanisms, particularly in ovx rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978806     DOI: 10.1016/j.toxlet.2006.08.003

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  5 in total

1.  Acute exposure to 4-OH-A, not PCB1254, alters brain aromatase activity but does not adversely affect growth in zebrafish.

Authors:  Cassie J Gould; Colin J Saldanha; Victoria P Connaughton
Journal:  Environ Toxicol Pharmacol       Date:  2019-03-14       Impact factor: 4.860

2.  Possible antiosteoporotic mechanism of Cicer arietinum extract in ovariectomized rats.

Authors:  Sohair R Fahmy; Amel M Soliman; Amany A Sayed; Mohamed Marzouk
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 3.  Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.

Authors:  Bayram Yilmaz; Hakan Terekeci; Suleyman Sandal; Fahrettin Kelestimur
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

4.  Inhibitory effects of morinda officinalis extract on bone loss in ovariectomized rats.

Authors:  Nan Li; Lu-Ping Qin; Ting Han; Yan-Bin Wu; Qiao-Yan Zhang; Hong Zhang
Journal:  Molecules       Date:  2009-06-08       Impact factor: 4.411

5.  Bone tissue morphology of rat offspring lactationally exposed to polychlorinated biphenyl 169 and 155.

Authors:  Jana Brankovič; Janja Jan; Gregor Fazarinc; Milka Vrecl
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.